Explore life science companies operating throughout Greater London, from biotechnology startups to global pharmaceutical organisations.
Pharmaceutical regulatory, batch release and wholesale distribution services
Wave Pharma is a pharmaceutical services company supporting generic medicine developers and new market entrants with regulatory, quality and supply chain services. It provides regulatory strategy and submissions, medical writing, batch release and quality assurance, GMP, GCP and GLP audits, and quality control…
Takeda's UK clinical development and drug discovery operations
Takeda UK encompasses the British operations of Takeda Pharmaceutical Company, one of the world's largest biopharmaceutical companies. The London-based Takeda Development Centre Europe leads clinical development, regulatory affairs, and medical affairs across oncology, neuroscience, gastrointestinal disease, rare…
Programmable gene control platform for advanced cell therapies
Laverock Therapeutics is a biotechnology company developing a programmable gene control platform for the creation of disease-responsive advanced therapies. The platform uses recoded microRNAs to deliver tunable, stable and multiplexed gene silencing within cell therapies, enabling enhanced precision and improved…
AI-powered cancer biomarker profiling from tissue images
Panakeia is an AI diagnostics company developing software that predicts molecular biomarker status directly from standard H&E-stained tissue images. Its CE-marked and UKCA-certified breast cancer product reports ER, PR, and HER2 status in minutes, reducing the need for conventional laboratory testing. The platform…
AI-driven enzyme discovery for sustainable industrial ingredients
Scindo is a UK biotechnology company developing an AI-powered enzyme discovery and engineering platform to produce bio-based alternatives to petroleum-derived industrial ingredients. The company combines machine learning with proprietary experimentally validated reaction datasets to discover and optimise enzymes…
Microbiome platform optimising hydroponic crop performance
Concert Bio is an agricultural biotechnology company developing microbial products to optimise crop performance in hydroponic greenhouses. Its platform combines the world's largest hydroponic microbiome database with machine learning to identify beneficial microbes tailored for soilless growing systems. The company's…
Biopharmaceutical group distributing and developing cannabis-based medicines
GROW Group is a biopharmaceutical company focused exclusively on cannabis-based medicines, operating through complementary distribution and research divisions. Its UK distribution arm, Grow Group UK, is a licensed GMP specials manufacturer supplying prescribed cannabinoid medicines to patients via specialist…
Synthetic psilocybin therapy for treatment-resistant depression and PTSD
Compass Pathways is a clinical-stage biopharmaceutical company developing synthetic psilocybin-based treatments for mental health conditions. Its lead candidate, COMP360, is a proprietary synthesised psilocybin formulation administered alongside structured psychological support. COMP360 holds FDA Breakthrough Therapy…
Monoclonal antibodies for viral infectious disease
RQ Biotechnology is a passive immunisation company discovering and developing long-acting monoclonal antibodies to provide immediate protection against viral infections in immunocompromised and vulnerable populations. Founded by members of the UK COVID-19 Antibody Taskforce and co-founded with LifeArc, the company's…
AI platform predicting patient response to cancer immunotherapy
Curenetics is a medical technology company developing AI-powered tools to predict cancer patient responses to immunotherapy before treatment begins. Its platform integrates multi-omic genomic data, imaging profiles and clinical information to identify biomarkers of treatment efficacy and toxicity. The company also…
Tissue-targeted gene and RNA delivery platforms for rare and neurological disease
Dawn Therapeutics is a pre-clinical biotechnology company developing precision delivery platforms for genetic medicines targeting the central nervous system, cartilage, and bone. Its transferrin receptor-guided system is designed to cross the blood-brain barrier and deliver RNA or DNA payloads to neuronal tissues,…
Topical peptide therapeutics targeting inflammatory skin disease
Carocell Bio is a pre-clinical stage biotechnology company developing proprietary peptide-based therapeutics for inflammatory diseases. Its pipeline centres on topical formulations that inhibit mitogen-activated protein kinase (MAPK/p38), a key regulator of the inflammatory cascade. Lead programmes target atopic…
Off-the-shelf Natural Killer cell therapies for solid and blood cancers
NK:IO develops cancer immunotherapies based on human Natural Killer cells, harnessing the body's innate immune system as an alternative to T-cell-based approaches. The company's patented platform activates cord blood-derived stem cells to produce NK cells at high potency and yield, addressing manufacturing challenges…
Virus-like particle vaccine platform for infectious disease and diagnostics
iQur is a London-based biotechnology company developing vaccines using its proprietary tandem core virus-like particle platform. The technology uses the hepatitis B virus core protein to display multiple antigens simultaneously, stimulating strong immune responses without the risks of live or attenuated viruses.…
Scientific and policy network advancing UK cannabinoid research
CRDG is a UK scientific and policy network working to strengthen cannabinoid research and pharmaceutical development. It connects researchers, clinicians, industry organisations and regulators to address barriers to cannabinoid studies, including research licensing, clinical trial approvals and funding access. Its…
Targeted magnetic blood filtration to enable gene therapies
MediSieve is a biotechnology company developing selective magnetic blood filtration using engineered particles that bind specific circulating biological targets. Its extracorporeal system combines target-specific magnetic beads with a capture device designed to remove bound substances before blood returns to the…
Oncolytic adenovirus therapeutics for solid tumour cancer treatment
PsiVac is a UK-based biotechnology company developing oncolytic virus therapeutics for the treatment of cancer. Its patented technology uses genetically modified adenoviruses engineered to selectively replicate within and destroy tumour cells while leaving healthy cells intact, while also stimulating the body's immune…
PCR reagents and mastermixes for molecular biology research and diagnostics
PCR Biosystems is a developer and manufacturer of PCR reagents for molecular biology research and in vitro diagnostics. Its product range includes DNA polymerases, reverse transcriptases, real-time PCR mastermixes, cDNA synthesis kits, and NGS library amplification reagents, with proprietary hot-start chemistry and…
Breath-based molecular liquid biopsies for early lung cancer detection
Respiro Diagnostics is a biotechnology company developing non-invasive molecular diagnostics for respiratory diseases, initially focusing on lung cancer. Its investigational platform collects exhaled breath samples and analyses lung-derived molecular biomarkers, including nucleic acids and proteins, to support earlier…
Cell-specific mRNA delivery platform for genetic medicines
Nuntius Therapeutics is a London-based biotechnology company developing mRNA therapies using proprietary peptide dendrimer and lipid-based nanocarriers designed to deliver genetic payloads to tissues and cell types beyond the liver. The platform combines machine learning-guided carrier design with engineered mRNA…